Evidence map›Paper›PMID 34066059›Full record

ArticleCells2021

Upregulation of Chemoresistance by Mg

Saki Onuma, Aya Manabe, Yuta Yoshino, Toshiyuki Matsunaga, Tomohiro Asai, Akira Ikari

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. The MicroalgaMolecules (Basel, Switzerland) · 2022
    Article
  4. Incorporation of a FRET Pair into a Riboswitch RNA to Measure MgInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Saki OnumaLaboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
Aya ManabeLaboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
Yuta YoshinoLaboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.
Toshiyuki MatsunagaEducation Center of Green Pharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 502-8585, Japan.
Tomohiro AsaiDepartment of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Akira IkariLaboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu 501-1196, Japan.ORCID 0000-0003-2696-0897
Gifu Pharmaceutical University · JPUniversity of Shizuoka · JP

Funding

Fuji Foundation for Protein Research AIJapan Society for the Promotion of Science 19H03373Kieikai Research Foundation AISmoking Research Foundation AITakeda Science Foundation AI
6 · The paper itself

Abstract

Several anticancer drugs including cisplatin (CDDP) induce hypomagnesemia. However, it remains fully uncertain whether Mg

Indexed as

Drug Resistance, NeoplasmA549 CellsAdenocarcinoma of LungATP Binding Cassette Transporter, Subfamily BCell CycleCell ProliferationCisplatinCyclosporinsDNA DamageDoxorubicinGene Expression Regulation, NeoplasticHumansImidazolesLung NeoplasmsLymph NodesMagnesiumABCB1 protein, humanATP Binding Cassette Transporter, Subfamily BCisplatinCyclosporinsDoxorubicinImidazolesMagnesiump38 Mitogen-Activated Protein KinasesPyridinesReactive Oxygen SpeciesRoscovitineSB 203580valspodarABCB1chemoresistancehypomagnesemialung adenocarcinoma

Identifiers

PMID34066059
PMCPMC8150369
OpenAlexW3162785582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.